People: Novartis AG (NOVN.VX)
Dr. Rolf M. Zinkernagel, M.D., serves as Member of the Board of Directors at Novartis AG since May 1999. He is Member of the Corporate Governance and Nomination Committee of the Company. Dr. Zinkernagel was Vice President of the International Union of Immunological Societies until 2010. He is Member of the scientific advisory boards of Bio-Alliance AG, Germany; Aravis General Partner Ltd., Cayman Islands and Switzerland; Telormedix, Switzerland; X-Biotech, Canada; Novimmune, Switzerland; Cancevir, Switzerland; Nuvo Research Inc., Canada; ImVision, Germany; MannKind, United States; and Biomedical Sciences International Advisory Council, Singapore. Dr. Zinkernagel is also a science consultant to Chilka Ltd., Cayman Islands; Ganymed, Germany; and Zhen-Ao Group, China. He is Member of the scientific advisory panel of Swiss Re, Switzerland. Dr. Zinkernagel graduated from Universitaet Basel, Switzerland, with a Doctor of Medicine (M.D.) in 1970. From 1992 to 2008, he was a professor and director of the Institute of Experimental Immunology at the University of Zurich and after his retirement in 2008, continues to be active at the University of Zurich. Dr. Zinkernagel has received awards and prizes for his work and contribution to science, notably the Nobel Prize in medicine, which he was awarded in 1996.
|Total Annual Compensation, CHF||Long-Term Incentive Plans, CHF||All Other, CHF||Fiscal Year Total, CHF|